News for ADMA Biologics Inc

GlobeNewswire 20d

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

TipRanks 20d

Adma Biologics options imply 10.9% move in share price post-earnings

Seeking Alpha 21d

Here are the major earnings after the close today

Seeking Alpha 21d

ADMA Biologics Q1 Earnings Preview

GlobeNewswire 28d

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025

TipRanks 28d

Cantor Fitzgerald Remains a Buy on ADMA Biologics (ADMA)

TipRanks 29d

Amazon sellers pull away from Prime Day, IBM to invest in U.S.: Morning Buzz

Seeking Alpha 30d

Biggest stock movers Monday: PLUG, TM, AMPY, and more

GlobeNewswire 30d

ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process

TipRanks 30d

Adma announces U.S. FDA approval of production yield enhancement process

TipRanks 40d

Biotech Alert: Searches spiking for these stocks today

Seeking Alpha 50d

Axogen and ADMA Biologics expect low to zero impact from recent tariffs

GlobeNewswire 51d

ADMA Biologics Statement on Tariffs

TipRanks 51d

ADMA Biologics reiterates ‘strategic advantage’ through U.S.-based manufacturing

TipRanks 81d

Biotech Alert: Searches spiking for these stocks today

TipRanks 82d

Biotech Alert: Searches spiking for these stocks today

Seeking Alpha 84d

ADMA Biologics slips as 10-K delay overshadows earnings beat

TipRanks 85d

Closing Bell Movers: Okta spikes 15% on earnings beat and outlook

GlobeNewswire 85d

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

TipRanks 85d

Adma Biologics reports Q4 EPS 46c, consensus 15c

TipRanks 85d

Adma Biologics sees FY25 revenue at least $490M, consensus $482.41M

TipRanks 85d

Adma Biologics sees FY26 revenue at least $605M

Seeking Alpha 85d

ADMA Biologics GAAP EPS of $0.46 beats by $0.31, revenue of $117.55M beats by $4.75M

TipRanks 85d

Adma Biologics options imply 11.5% move in share price post-earnings

Seeking Alpha 86d

Here are the major earnings after the close today

TipRanks 86d

Options Volatility and Implied Earnings Moves Today, March 03, 2025

TipRanks 86d

Options Volatility and Implied Earnings Moves This Week, March 03 – March 06, 2025

Seeking Alpha 86d

ADMA Biologics Q4 2024 Earnings Preview

Seeking Alpha 87d

Earnings week ahead: TGT, COST, CRWD, AVGO, JD, PLUG, MRVL, and more

GlobeNewswire 89d

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

GlobeNewswire 92d

ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

TipRanks 133d

Mizuho Securities Keeps Their Buy Rating on ADMA Biologics (ADMA)

GlobeNewswire 135d

ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update

TipRanks 135d

Adma Biologics sees FY26 revenue $600M

TipRanks 135d

Adma Biologics reports preliminary FY24 revenue $417M-$425M, consensus $423.19M

TipRanks 135d

Adma Biologics sees FY25 revenue $485M, consensus $486.79M

GlobeNewswire 141d

ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025

GlobeNewswire 159d

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

TipRanks 159d

Adma Biologics announces partial paydown of senior term loan credit facility

TipRanks 176d

Mizuho Securities Remains a Buy on ADMA Biologics (ADMA)

TipRanks 187d

ADMA Biologics Announces Board Resignations and Appointments

TipRanks 201d

Adma Biologics price target raised to $26 from $18 at H.C. Wainwright

TipRanks 201d

ADMA Biologics Reports Robust Q3 2024 Growth

TipRanks 201d

Closing Bell Movers: Toast gains 19% afterhours after earnings beat

GlobeNewswire 201d

ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update

TipRanks 201d

Adma Biologics reports Q3 EPS 15c, consensus 13c

Seeking Alpha 201d

ADMA Biologics GAAP EPS of $0.15 beats by $0.02, revenue of $119.8M beats by $13.95M

TipRanks 201d

Adma Biologics options imply 13.3% move in share price post-earnings

Seeking Alpha 202d

Here are the major earnings after the close today

Seeking Alpha 202d

ADMA Biologics Q3 2024 Earnings Preview

	
		OSZAR »